Semaphorin 3d signaling defects are associated with anomalous pulmonary venous connections
Karl Degenhardt(Children's Hospital of Philadelphia), Jonathan A. Epstein(California Institute for Regenerative Medicine), Daniele Massera(California Institute for Regenerative Medicine), Manvendra K. Singh(National Heart Centre Singapore), Emily Gallant(Children's Hospital of Philadelphia), Amanda D. Yzaguirre(Cancer Research Institute), Connie Choi(California Institute for Regenerative Medicine), Qiaohong Wang(University of Pennsylvania), Peter J. Gruber(University of Utah), Haig Aghajanian(Therapeutics Clinical Research), Li Li(Army Medical University), Jun Li(Tangshan Gongren Hospital), Lauren J. Francey(Cincinnati Children's Hospital Medical Center), Ian D. Krantz(Children's Hospital of Philadelphia)
Cited by 81
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|792
Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force
|Genetics in Medicine|2002|398
Plasticity of Hopx+ type I alveolar cells to regenerate type II cells in the lung
|Nature Communications|2015|309
Guidelines for Genome-Scale Analysis of Biological Rhythms
|Journal of Biological Rhythms|2017|302